Zeno Health, a Mumbai, India-based omnichannel platform for generic medicines, closed its USD25m Series C funding.

总部位于印度孟买的仿制药全渠道平台Zeno Health关闭了2500万美元的C系列资金。

The round was led by STIC Investments with participation from existing investor Lightbox.

本轮投资由STIC投资牵头，现有投资者Lightbox参与。

The company intends to use the funds to expand operations and its business reach, and grow its development efforts.

该公司打算利用这些资金扩大运营和业务范围，并加大发展力度。

Founded in 2017 by IIT Bombay alumni- Siddharth Gadia and Girish Agarwal, Zeno Health is a generic medicine focussed pharmacy with a widespread presence in Mumbai and Pune with 175+ stores.

Zeno Health由IIT孟买校友Siddharth Gadia和Girish Agarwal于2017年成立，是一家以仿制药为主的药店，在孟买和浦那拥有175多家门店。

The company says it serves more than 25+ lakh customers, generating 550+ Crores in savings and counting.

该公司表示，它为250多万客户提供服务，节省和计算了5.5亿美元。